Quivive Pharma, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Investigate the Safety, Tolerability and Pharmacokinetics of QEV-817 Oral Suspension (NCT06585163) | Quivive Pharma, Inc. | 2025-08-18 |
Track Quivive Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.